In 2014 the Netherlands switched from 3 to 2 doses for routine vaccination with the prophylactic bivalent human papillomavirus (HPV) vaccine. The current study explored whether antibody responses are noninferior after 2 versus 3 doses in girls
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
In 2014 the Netherlands switched from 3 to 2 doses for routine vaccination with the prophylactic biv...
BACKGROUND: In 2014 the Netherlands switched from three- to two-doses for routine vaccination with t...
In this cohort study, we examined antibody levels and avidity after a two-dose schedule (0, 6 months...
The bivalent human papillomavirus (HPV) vaccine is highly effective and induces robust serological r...
The bivalent human papillomavirus (HPV) vaccine is highly effective and induces robust serological r...
BACKGROUND: In the Netherlands, the bivalent human papillomavirus (HPV) vaccine has been offered to ...
BACKGROUND: In the Netherlands, the bivalent human papillomavirus (HPV) vaccine has been offered to ...
BACKGROUND AND OBJECTIVES: Human papillomavirus (HPV) antibody responses to the 9-valent human papil...
Background Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for assess...
Background and objectives: Human papillomavirus (HPV) antibody responses to the 9-valent human papil...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
In 2014 the Netherlands switched from 3 to 2 doses for routine vaccination with the prophylactic biv...
BACKGROUND: In 2014 the Netherlands switched from three- to two-doses for routine vaccination with t...
In this cohort study, we examined antibody levels and avidity after a two-dose schedule (0, 6 months...
The bivalent human papillomavirus (HPV) vaccine is highly effective and induces robust serological r...
The bivalent human papillomavirus (HPV) vaccine is highly effective and induces robust serological r...
BACKGROUND: In the Netherlands, the bivalent human papillomavirus (HPV) vaccine has been offered to ...
BACKGROUND: In the Netherlands, the bivalent human papillomavirus (HPV) vaccine has been offered to ...
BACKGROUND AND OBJECTIVES: Human papillomavirus (HPV) antibody responses to the 9-valent human papil...
Background Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for assess...
Background and objectives: Human papillomavirus (HPV) antibody responses to the 9-valent human papil...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...
Background. Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for asses...